J&J Pushes Back on Market Reaction to Patient Trial of Its Lung Cancer Drug

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Johnson & Johnson pushed back on market reaction to a trial of its lung cancer combination therapy after some analysts said the results don’t measure up to another widely used option.

Tesla profit disappoints after deliveries slow downSpaceX Says It’s ‘Hard to Say’ When Starship Will Be Moon-ReadyDelta Rolls Back Loyalty Program Changes That Steamed TravelersBiden’s Whirlwind Israel Trip Fails to Calm Fears of Wider Middle East Conflict‘South Park’ Creators in Talks With Carlyle for New Private LoanNYSE, Nasdaq Volume Discounts for Brokerages Threatened by SECTrudeau Warns Alberta Against Exiting National Pension FundDevon Energy Mulls M&A Options With Marathon,...

29 for Stellantis strike deadline as talks set to beginChampagne says he wishes grocers were more 'forthcoming' on plans to stabilize pricesFood inflation eased last month, but prices still high: StatCanWhat do Tuesday's inflation numbers mean for the Bank of Canada?What are economists expecting from Tuesday's inflation report?'It's not the grocery store's fault': money manager on food inflationThe Daily Chase: Tourmaline Oil to buy Bonavista EnergyIsrael Latest:...

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 83. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し